SCHEMBL5578303

SCHEMBL5578303

O=[N+]([O-])c1c[nH]c(-c2cc[nH]n2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920099 0.78 ALDH1A1 (0.33) —
SCHEMBL2227297 0.73 METAP1 (0.52) —
SCHEMBL990710 0.71 MAPT (0.48) —
SCHEMBL27996263 0.70 XDH (0.33) —
SCHEMBL938 0.70 — —
SCHEMBL5578315 0.70 — —
SCHEMBL1602461 0.70 ALDH1A1 (0.34) —
Hydrochloric Acid SCHEMBL27975795 0.69 — —
Charcoal, Activated SCHEMBL30986727 0.69 — —
SCHEMBL1066878 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105900-A1 Pharmaceutical compounds ATEX THERAPEUTICS, LIMITED (GB) 2007-05-10 — — US disclosed
EP-1648449-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS Astex Therapeutics Limited (GB) 2006-04-26 — — EP disclosed
WO-2005002576-A2 IMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2005-01-13 — — WO disclosed
Send feedback